These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 26051304

  • 1. Adolescents with gender dysphoria.
    Cohen-Kettenis PT, Klink D.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):485-95. PubMed ID: 26051304
    [Abstract] [Full Text] [Related]

  • 2. Gender-affirming hormones and surgery in transgender children and adolescents.
    Mahfouda S, Moore JK, Siafarikas A, Hewitt T, Ganti U, Lin A, Zepf FD.
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
    [Abstract] [Full Text] [Related]

  • 3. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE, Wouters FM, Cohen-Kettenis PT, Gooren LJ, Hannema SE.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):e4252-63. PubMed ID: 32909025
    [Abstract] [Full Text] [Related]

  • 4. Current approach to the clinical care of adolescents with gender dysphoria.
    Kyriakou A, Nicolaides NC, Skordis N.
    Acta Biomed; 2020 Mar 19; 91(1):165-175. PubMed ID: 32191677
    [Abstract] [Full Text] [Related]

  • 5. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
    Schagen SEE, Lustenhouwer P, Cohen-Kettenis PT, Delemarre-van de Waal HA, Hannema SE.
    J Sex Med; 2018 Sep 19; 15(9):1357-1363. PubMed ID: 30224022
    [Abstract] [Full Text] [Related]

  • 6. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG.
    J Clin Endocrinol Metab; 2017 Nov 01; 102(11):3869-3903. PubMed ID: 28945902
    [Abstract] [Full Text] [Related]

  • 7. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC, Klink DT, Hannema SE, Bruinsma S, Steensma TD, Kreukels BPC, Cohen-Kettenis PT, de Vries ALC, den Heijer M, Wiepjes CM.
    J Sex Med; 2023 Feb 27; 20(3):398-409. PubMed ID: 36763938
    [Abstract] [Full Text] [Related]

  • 8. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
    Fisher AD, Ristori J, Romani A, Cassioli E, Mazzoli F, Cocchetti C, Pierdominici M, Marconi M, Ricca V, Maggi M, Vignozzi L, Castellini G.
    J Clin Endocrinol Metab; 2024 May 17; 109(6):1565-1579. PubMed ID: 38099569
    [Abstract] [Full Text] [Related]

  • 9. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE, de Vries MC, Hannema SE.
    J Sex Med; 2019 Sep 17; 16(9):1459-1468. PubMed ID: 31405768
    [Abstract] [Full Text] [Related]

  • 10. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP, Madison CM, Milne NM.
    Pharmacotherapy; 2014 Dec 17; 34(12):1282-97. PubMed ID: 25220381
    [Abstract] [Full Text] [Related]

  • 11. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan 17; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

  • 12. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
    Klink D, Caris M, Heijboer A, van Trotsenburg M, Rotteveel J.
    J Clin Endocrinol Metab; 2015 Feb 17; 100(2):E270-5. PubMed ID: 25427144
    [Abstract] [Full Text] [Related]

  • 13. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
    Nieder TO, Briken P, Richter-Appelt H.
    Psychother Psychosom Med Psychol; 2014 Jun 17; 64(6):232-45. PubMed ID: 24892869
    [No Abstract] [Full Text] [Related]

  • 14. [Health care for adolescents with gender dysphoria].
    Fernández M, Guerra P, Martín E, Martínez N, Álvarez-Diz JA, Grupo GIDSEEN..
    Rev Esp Salud Publica; 2018 Feb 28; 92():. PubMed ID: 29493565
    [Abstract] [Full Text] [Related]

  • 15. Treatment of adolescents with gender dysphoria in the Netherlands.
    Cohen-Kettenis PT, Steensma TD, de Vries AL.
    Child Adolesc Psychiatr Clin N Am; 2011 Oct 28; 20(4):689-700. PubMed ID: 22051006
    [Abstract] [Full Text] [Related]

  • 16. The effect of early puberty suppression on treatment options and outcomes in transgender patients.
    Panagiotakopoulos L, Chulani V, Koyama A, Childress K, Forcier M, Grimsby G, Greenberg K.
    Nat Rev Urol; 2020 Nov 28; 17(11):626-636. PubMed ID: 32968238
    [Abstract] [Full Text] [Related]

  • 17. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L, Segev-Becker A, Israeli G, Elkon-Tamir E, Oren A.
    LGBT Health; 2020 Nov 28; 7(6):340-344. PubMed ID: 32735503
    [Abstract] [Full Text] [Related]

  • 18. Endocrinology of Transgender Medicine.
    T'Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V.
    Endocr Rev; 2019 Feb 01; 40(1):97-117. PubMed ID: 30307546
    [Abstract] [Full Text] [Related]

  • 19. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y.
    Seishin Shinkeigaku Zasshi; 2017 Feb 01; 119(1):42-51. PubMed ID: 30629867
    [Abstract] [Full Text] [Related]

  • 20. Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis.
    Abel BS.
    Hastings Cent Rep; 2014 Sep 01; 44 Suppl 4():S23-7. PubMed ID: 25231782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.